Next 10 |
home / stock / zldaf / zldaf news
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF) said that it has funding to conduct mid-to-late-stage FDA trials for its cannabinoid-based drug to treat autism spectrum disorder (ASD). The company received $8.6 million in funding from U.S.-based investment firm Cantheon Capital LLC to con...
Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets PR News...
Zelira Therapeutics Ltd (ASX: ZLD,OTC-QB: ZLDAF ), recieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market for its new insomnia medication Zenivol. Zenivol is the first clinically validated , pharmaceutic...
Zelira's Zenivol™, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany PR Newswire PHILADELPHIA , July 21, 2022 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTC-QB: ZLDAF), a...
Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary PR Newswire PHILADELPHIA , Sept. 23, 2021 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the researc...
Over the past five years, awareness about the medicinal properties of CBD has been growing. Although Australia’s cannabis industry is still young, CBD hasn’t escaped market watchers’ attention. CBD is a cannabidiol, meaning it is a compound found in the actual...
Mexico with 121 million citizens will likely legalize cannabis by April of this year opening the door to the largest population for potential customers; This will be a game-changing tipping point for legalization of cannabis around the world and especially throughout Latin America; ...
Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...
Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...
Both Senate seats went to Democrats and this allows for a blue agenda with cannabis legalization being one of the top priorities. Arizona's legalization of recreational cannabis is already being geared up for with companies retooling in preparation. The industry will see continued...
News, Short Squeeze, Breakout and More Instantly...
Zelda Therapeutics Ltd Company Name:
ZLDAF Stock Symbol:
OTCMKTS Market:
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF) said that it has funding to conduct mid-to-late-stage FDA trials for its cannabinoid-based drug to treat autism spectrum disorder (ASD). The company received $8.6 million in funding from U.S.-based investment firm Cantheon Capital LLC to con...
Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets PR News...
Zelira Therapeutics Ltd (ASX: ZLD,OTC-QB: ZLDAF ), recieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market for its new insomnia medication Zenivol. Zenivol is the first clinically validated , pharmaceutic...